In 2022, PureHealth, an ADX-listed healthcare platform, undertook a key acquisition by acquiring 100% equity interest in Tamouh Healthcare LLC, a significant player in health services and tourist investment in Abu Dhabi. Sen & Ray was honored to advise PureHealth through this complex transaction, delivering critical insights that shaped the acquisition’s strategic benefits.
Context of the Acquisition
Tamouh Healthcare LLC, registered in Abu Dhabi, contributes substantial revenue and profit to PureHealth, having generated AED 1.4 billion in revenue and AED 737 million in net profit in the first year post-acquisition. The acquisition was structured uniquely with no direct purchase consideration, reflecting broader strategic consolidation under PureHealth’s growth vision.
Sen & Ray’s Role: Financial Reporting & Asset Viability Analysis
Our advisory went beyond traditional due diligence, providing PureHealth’s leadership with a clear and comprehensive picture of Tamouh Healthcare’s underlying financial health, including its subsidiaries. Key contributions included:
- Detailed Reporting of Net Financial Position:
- Assessment of Asset Viability:
- Strategic Recommendations:
- Integration Support:
Enabling Future Growth
The acquisition strengthened PureHealth’s position as a leading healthcare conglomerate in the UAE, allowing the group to expand its service offerings and market reach substantially. Sen & Ray’s role in delivering transparent, insightful financial advisory played a pivotal part in the successful acquisition and paved the way for strategic operational integration and sustainable growth.
Client
